Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease.

Autor: Stork M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic. stork.martin@fnbrno.cz., Ondrouskova E; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Bohunova M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Boichuk I; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Fric D; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Adam Z; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Krejci M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Sandecka V; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Knechtova Z; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Radova L; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic., Jelinkova Z; Department of Burns and Plastic Surgery, University Hospital Brno and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic., Adlerova T; Department of Burns and Plastic Surgery, University Hospital Brno and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic., Krticka M; Trauma Surgery Department, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Nekuda V; Trauma Surgery Department, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Borsky M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Sevcikova S; Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Jarosova M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Department of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic., Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Publikováno v: Blood cancer journal [Blood Cancer J] 2024 Aug 26; Vol. 14 (1), pp. 146. Date of Electronic Publication: 2024 Aug 26.

SurVolT: Surface to Volume conversion Tool. A proof of concept.

Autor: Gorecki A; Department of Radiotherapy, Daniel Hollard Cancer Institute, Grenoble, France; School of Medical Physics, Faculty of Medicine, Grenoble Alpes University, France. Electronic address: alexia.gorecki@gmail.com., Sorgato V; Department of Radiotherapy, Daniel Hollard Cancer Institute, Grenoble, France; School of Medical Physics, Faculty of Medicine, Grenoble Alpes University, France., Mazzara C; Department of Radiotherapy, Daniel Hollard Cancer Institute, Grenoble, France., Clément S; Department of Radiotherapy, Daniel Hollard Cancer Institute, Grenoble, France., Fric D; Department of Radiotherapy, Daniel Hollard Cancer Institute, Grenoble, France., Farah J; Vision RT Ltd., Dove House, Arcadia Ave, Finchley, London N3 2JU, United Kingdom.

Publikováno v: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) [Phys Med] 2023 Apr; Vol. 108, pp. 102566. Date of Electronic Publication: 2023 Mar 28.

Analyse rétrospective de 108 carcinomes canalaires in situ mammaires traités par association radiochirurgicale

Autor: Fourneret, P., Artignan, X., De Cornulier, J., Pasquier, D., Panh, M.-H., Payan, R., Kolodié, H., Vincent, F., Fric, D., Bernard, P., Colona, M., Bolla, M.

Publikováno v: In Cancer / Radiothérapie 2006 10(8):550-558

Benchmarking the AlignRT surface deformation module for the early detection and quantification of oedema in breast cancer radiotherapy.

Autor: Sorgato V; Department of Radiotherapy, Daniel Hollard Cancer Institute, Grenoble, France., Ghazouani K; School of Medical Physics, Faculty of Medicine, Grenoble Alpes University, France., Queffelec Y; Vision RT Ltd., Dove House, Arcadia Ave, Finchley, London N3 2JU, United Kingdom., Julia F; Department of Radiotherapy, Daniel Hollard Cancer Institute, Grenoble, France., Clement S; Department of Radiotherapy, Daniel Hollard Cancer Institute, Grenoble, France., Fric D; Department of Radiotherapy, Daniel Hollard Cancer Institute, Grenoble, France., Farah J; Vision RT Ltd., Dove House, Arcadia Ave, Finchley, London N3 2JU, United Kingdom.

Publikováno v: Technical innovations & patient support in radiation oncology [Tech Innov Patient Support Radiat Oncol] 2022 Jan 15; Vol. 21, pp. 16-22. Date of Electronic Publication: 2022 Jan 15 (Print Publication: 2022).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.